Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach
Breast cancer is one of the most commonly occurring cancers in women globally and is the primary cause of cancer mortality in females. BC is highly heterogeneous with various phenotypic expressions. The overexpression of HER2 is responsible for 15–30% of all invasive BC and is strongly associated wi...
Main Authors: | Chris Vi, Giovanni Mandarano, Sarah Shigdar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/11/6163 |
Similar Items
-
Radiolabeled Antibodies for Cancer Imaging and Therapy
by: Sagun Parakh, et al.
Published: (2022-03-01) -
Radiolabelled Aptamers for Theranostic Treatment of Cancer
by: Umair Khalid, et al.
Published: (2018-12-01) -
Scandium Radioisotopes—Toward New Targets and Imaging Modalities
by: Krzysztof Kilian, et al.
Published: (2023-11-01) -
Nanobody-Based Theranostic Agents for HER2-Positive Breast Cancer: Radiolabeling Strategies
by: Ivanna Hrynchak, et al.
Published: (2021-10-01) -
Aptamer-based therapeutics and their potential in radiopharmaceutical design
by: Catia S. M. Ferreira, et al.
Published: (2007-09-01)